BIT — Biotron Cashflow Statement
0.000.00%
- AU$4.65m
- AU$3.71m
Annual cashflow statement for Biotron, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -3.49 | -2.62 | -2.95 | -3.55 | -0.723 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3.41 | -2.44 | -3.29 | -3.57 | -0.566 |
Capital Expenditures | -0.006 | 0 | 0 | 0 | -0.003 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -0.006 | 0 | 0 | 0 | -0.003 |
Financing Cash Flow Items | 0 | — | -0.428 | — | -0.167 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.037 | -0.033 | 5.53 | -0.023 | 1.11 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.45 | -2.47 | 2.24 | -3.59 | 0.538 |